Figure 1From: Abatacept (CTLA4Ig) treatment increases the remission rate in rheumatoid arthritis patients refractory to methotrexate treatmentAbatacept increases the remission rate in RA patients refractory to MTX treatment. Means and 95% confidence intervals are shown.Back to article page